Management of glioma in Victoria (1998-2000): retrospective cohort study

Rosenthal, Mark A., Drummond, Katharine J., Dally, Michael, Murphy, Michael, Cher, Lawrence, Ashley, David, Thursfield, Vicky and Giles, Graham G. 2006, Management of glioma in Victoria (1998-2000): retrospective cohort study, Medical journal of Australia, vol. 184, no. 6, pp. 270-273.

Attached Files
Name Description MIMEType Size Downloads

Title Management of glioma in Victoria (1998-2000): retrospective cohort study
Author(s) Rosenthal, Mark A.
Drummond, Katharine J.
Dally, Michael
Murphy, Michael
Cher, Lawrence
Ashley, David
Thursfield, Vicky
Giles, Graham G.
Journal name Medical journal of Australia
Volume number 184
Issue number 6
Start page 270
End page 273
Total pages 4
Publisher Australasian Medical Publishing Company
Place of publication Sydney, N.S.W.
Publication date 2006-03-20
ISSN 0025-729X
Keyword(s) Adolescent
Aged, 80 and over
Antineoplastic Agents
Cohort Studies
Combined Modality Therapy
Follow-Up Studies
Health Care Surveys
Medical Oncology
Middle Aged
Outcome and Process Assessment (Health Care)
Practice Patterns, Physicians'
Referral and Consultation
Retrospective Studies
Survival Analysis
Summary OBJECTIVE: To describe the management of and outcomes in a population-based cohort of patients with newly diagnosed glioma. DESIGN, SETTING AND PATIENTS: Retrospective cohort study of patients with glioma newly diagnosed over the period 1998-2000 in Victoria. Patients were identified from the population-based Victorian Cancer Registry (VCR). Doctors involved in managing the patients were surveyed by a questionnaire sent out in 2003. The cohort was followed until the end of 2004 to obtain at least 4 years' follow-up data on all patients. MAIN OUTCOME MEASURES: Reported treatment, referral patterns and survival rates. RESULTS: Over the study period, 992 cases of glioma were identified; 828 completed surveys on eligible patients were obtained (response rate, 93%); 473 patients (57%) had glioblastoma multiforme (GBM); 105 patients (13%) diagnosed with "glioma" had had no histological confirmation. Complete macroscopic resection was performed in 209 patients (25%); 612 patients (74%) were referred for radiotherapy and 326 (54%) for chemotherapy; 39 (5%) were enrolled on a clinical trial. Median survival was 9.2 months for all patients and 7.4 months for patients with GBM. CONCLUSIONS: This is the largest reported glioma management survey in the world to date. Much of the patient demographics and approach to treatment were as expected and represent a reasonable "standard of care". However, there are some areas for improvement, including the absence of histological diagnosis in some patients, lack of multidisciplinary care, low clinical trial enrollment and poor use of ancillary services.
Language eng
Field of Research 1117 Public Health And Health Services
1103 Clinical Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2006, Medical Journal of Australia
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 30 times in TR Web of Science
Scopus Citation Count Cited 43 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 246 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 17 Mar 2015, 11:01:49 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact